Semaglutide, the GLP-1 agonist, is the active ingredient in popular diabetes (Ozempic® and Rybelsus®) and weight loss drugs (Wegovy®). When used correctly, Semaglutide’s anti-hyperglycaemic activity and success in weight management have been firmly established.
Patients frequently wonder how long Semaglutide takes to work after beginning Semaglutide treatment and what to expect with each subsequent dose increase.
This Semaglutide’s monthly roadmap is a guideline to help you understand what to expect during your Semaglutide treatment journey. Always follow your healthcare provider’s instructions and tailor your monthly roadmap to your health needs.